Test Overview
AASCA, GASCA: Enzyme-Linked Immunosorbent Assay (ELISA)
NSA: Indirect Immunofluorescent Assay (IFA)
As an adjunct in the diagnosis of ulcerative colitis and Crohn disease in patients suspected of having inflammatory bowel disease
Saccharomyces cerevisiae ANTIBODY, IgA or IgG
Negative: < or =20.0 U; Equivocal: 20.1-24.9 U; Weakly positive: 25.0-34.9 U; Positive: > or =35.0 U
Neutrophil specific antibodies: Negative (not detected)
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Not useful to determine the extent of disease in patients with inflammatory bowel disease (IBD) or determine the response to disease-specific therapy including surgical resection of diseased intestine
Test Details
2 - 10 days
- IBD
Specimen Requirements
Collect specimen in an SST or red top tube. Spin, aliquot into a screw capped plastic tube and send to Specimen Processing refrigerated.
Additional Information
Test performed by Mayo Clinic Laboratories